Last reviewed · How we verify
Ospedale Santa Croce-Carle Cuneo — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
2 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Oncology · 2
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- GlaxoSmithKline · 2 shared drug classes
- Alexion Pharmaceuticals, Inc. · 1 shared drug class
- Baxalta now part of Shire · 1 shared drug class
- Arbeitsgemeinschaft medikamentoese Tumortherapie · 1 shared drug class
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- Azienda Ospedaliera Universitaria Integrata Verona · 1 shared drug class
- Amgen · 1 shared drug class
- AgeneBio · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Ospedale Santa Croce-Carle Cuneo:
- Ospedale Santa Croce-Carle Cuneo pipeline updates — RSS
- Ospedale Santa Croce-Carle Cuneo pipeline updates — Atom
- Ospedale Santa Croce-Carle Cuneo pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Ospedale Santa Croce-Carle Cuneo — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ospedale-santa-croce-carle-cuneo. Accessed 2026-05-16.